Skip to main navigation
logo

Investor Navigation

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • SEC Filings
  • Governance
    • Documents & Charters
    • Board of Directors
    • Executive Team
    • Committee Composition
  • IR Resources
    • Investor FAQ
    • Contact IR
    • Email Alerts

Press Releases

11 May '2022
Context Therapeutics® Reports First Quarter 2022 Operating and Financial Results
05 May '2022
Context Therapeutics® Announces Poster Presentation at the Upcoming 2022 ASCO Annual Meeting
11 Apr '2022
Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
06 Apr '2022
Context Therapeutics® to Participate in Two April 2022 Investor Conferences
23 Mar '2022
Context Therapeutics® Reports Full Year 2021 Operating and Financial Results
08 Mar '2022
Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
22 Feb '2022
Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO Forum
05 Jan '2022
Context Therapeutics® Strengthens Research & Development Team
04 Jan '2022
Context Therapeutics® to Participate in Two January 2022 Investor Conferences

Investor Tools

  • Print Page
  • RSS Feeds
  • Search

© 2022 Context Therapeutics Inc.     All rights reserved.